Related Experiment Video

Updated: Dec 25, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

470

Understanding the results of the PARAGON-HF trial

Roberto Ferrari1,2, Alessandro Fucili1, Claudio Rapezzi1,2

  • 1Centro Cardiologico Universitario di Ferrara, University of Ferrara, Ferrara, Italy.

European Journal of Heart Failure
|March 27, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

854
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.6K

Related Experiment Videos

Last Updated: Dec 25, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

470
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

854
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.6K

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

483
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
483

Articles linked to this work by shared authors, journal, and citation graph.

Clinical, Transcriptional and Haplotype Characterization of Recurrent MYBPC3 Splice-Site Variants c.1458-1G>A and c.3331-1G>A Associated with Hypertrophic Cardiomyopathy in Northern Italy.

Genes·2026

Management of hyperkalaemia in the Italian clinical practice: impact of diverse potassium binders on outcomes and costs in patients with chronic kidney disease and heart failure.

International urology and nephrology·2026

Management of patients with cardiovascular disease and overweight/obesity: expert opinion on semaglutide use.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026

Efficacy of ARNIs on hard renal outcomes in heart failure with and without chronic kidney disease: when endpoint definition matters-an updated meta-analysis.

ESC heart failure·2026

SGLT2 inhibitors and risk of atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis of observational studies.

Heart rhythm O2·2026

SGLT2 inhibitors and risk of new-onset left bundle branch block in heart failure with preserved ejection fraction.

International journal of cardiology·2026

Efficacy of Vericiguat by Background Guideline-Directed Medical Therapy in the VICTOR Trial.

European journal of heart failure·2026

RSV vaccine for preventing respiratory and cardiovascular hospitalizations in heart failure: a prespecified analysis of the extended DAN-RSV trial.

European journal of heart failure·2026

Early and Late TAVI Outcomes in Aortic Stenosis with Transthyretin Cardiac Amyloidosis: A Systematic Review.

European journal of heart failure·2026

Contemporary decongestion strategies in acute heart failure: an individual patient data analysis of three randomized controlled trials.

European journal of heart failure·2026

Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry.

European journal of heart failure·2026

Gut microbiome-derived metabolites as prognostic biomarkers in heart failure: a systematic review and meta-analysis.

European journal of heart failure·2026

First Experience With Using a Simulator in Teaching Physiology of the Cardiovascular System.

Physiological research·2026

Human Disharmony Loop: The Role of the Pectoralis Minor in Thoracic Outlet Syndrome.

Plastic and reconstructive surgery. Global open·2026

Spinal manipulation in acute low back pain patients is associated with reduced motor-unit firing variability without altering bilateral coordination: a single-motor-unit EMG study of the lumbar multifidus.

Chiropractic & manual therapies·2026

[External diaphragm pacemaker combined with respiratory muscle training for pneumoconiosis with nonspecific low back pain: a randomized controlled trial].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2026

A latent burden-HVPG mathematical framework for threshold mapping and delay-differential scenario analysis in portal hypertension.

Mathematical biosciences and engineering : MBE·2026

Left bundle branch pacing is a superior pacing strategy compared to left ventricular septal pacing: insights from the pooled clinical evidence.

Frontiers in physiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us